


TXINNO Bioscience INC
Pharmaceutical Manufacturing • 수지구 광교중앙로 338, (상현동, Korea, Republic of • 11-20 Employees
Company overview
| Headquarters | 수지구 광교중앙로 338, (상현동, 광교우미뉴브) C동 707호, 용인, 경기도, KR |
| Phone number | +82317788688 |
| Website | |
| NAICS | 3254 |
| Keywords | LIN, Ba/F3, Ras 변이 항암제, Tmed, 선천면역항암제, 저분자 약물 개발, 혁신항암제 |
| Founded | 2020 |
| Employees | 11-20 |
| Socials |
Key Contacts at TXINNO Bioscience INC
Jong Heun Lee
Managing Director/Cdo
Eunmyong Lee
Director
Hongjun Kang
Director
TXINNO Bioscience INC Email Formats
TXINNO Bioscience INC uses 2 email formats. The most common is {first initial} (e.g., j@txinno.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@txinno.com | 50% |
{first name} | john@txinno.com | 50% |
About TXINNO Bioscience INC
주)티씨노바이오사이언스는 저분자 혁신항암제(표적항암제/면역항암제) 파이프라인과 선천면역항암제 평가기술인 LIN/TMED, Kinase 저해제 평가기술인 Ba/F3 평가계 등의 핵심 플랫폼 기술을 확보 및 구축하여 2020년에 9월에 설립한 KIST 기술출자 바이오 벤처입니다. 현재 RAS 관련 표적항암제 3개의 파이프라인과 선천면역항암제 2개의 파이프라인을 연구 개발 중입니다.
TXINNO Bioscience INC revenue & valuation
| Annual revenue | $1,197,770 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $3,900,000 |
| Total funding | $1,500,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
TXINNO Bioscience INC has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
Explore TXINNO Bioscience INC's funding history, including investment rounds, total capital raised, and key backers.
TXINNO Bioscience INC Tech Stack
Discover the technologies and tools that power TXINNO Bioscience INC's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
UI frameworks
JavaScript libraries
CDN
Web servers
JavaScript libraries
Programming languages
UI frameworks
SSL/TLS certificate authorities
JavaScript libraries
CDN
Frequently asked questions
4.8
40,000 users



